Dr Anne Dobrée



As Head of Seed Funds at Cambridge Enterprise, Anne has overseen strong growth in the University of Cambridge’s investment activities, with Seed Funds investing over £5 million each year in young companies.Highlights include the purchase of Cambridge CMOS Sensors by ams, and the sale of Quethera to Astellas Pharma. Anne has also served on many boards including those of Cambridge CMOS Sensors, Aqdot, Cambridge Touch Technologies, Psyomics, Morphogen-IX and Quethera. She was a founding member of Praxis Auril, which supports Knowledge Exchange Commercialisation in the UK.

Founder & CEO
Founder & CTO
Non Executive Director